Patents by Inventor Lue Dai

Lue Dai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combined treatment with a TLR7 agonist and an HBV capsid assembly inhibitor
    Patent number: 11771699
    Abstract: The present invention is directed to compositions and methods for treating hepatitis B virus infection. In particular, the present invention is directed to a combination therapy comprising administration of a TLR7 agonist and an HBV capsid assembly inhibitor for use in the treatment of chronic hepatitis B patient.
    Type: Grant
    Filed: September 15, 2017
    Date of Patent: October 3, 2023
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Lue Dai, Lu Gao
  • HEXAHYDRO-1H-PYRAZINO[1,2-A]PYRAZINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE
    Publication number: 20220340597
    Abstract: The present invention relates to compounds of formula (I), wherein R1 to R3, n and A are as described herein, and their pharmaceutically acceptable salt thereof, and compositions including the compounds and methods of using the compounds.
    Type: Application
    Filed: April 7, 2020
    Publication date: October 27, 2022
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Wei ZHU, Zhiwei ZHANG, Zhisen ZHANG, Hong SHEN, Yongfu LIU, Yafei LIU, Haixia LIU, Buyu KOU, Fabian DEY, Lue DAI, Linuo ZHU
  • Combined treatment with a TLR7 agonist and an HBV capsid assembly inhibitor
    Patent number: 11337982
    Abstract: The present invention is directed to compositions and methods for treating hepatitis B virus infection. In particular, the present invention is directed to a combination therapy comprising administration of a TLR7 agonist and an HBV capsid assembly inhibitor for use in the treatment of chronic hepatitis B patient.
    Type: Grant
    Filed: March 13, 2019
    Date of Patent: May 24, 2022
    Assignee: Hoffmann-La Roche, Inc.
    Inventors: Lue Dai, Lu Gao
  • COMBINED TREATMENT WITH A TLR7 AGONIST AND AN HBV CAPSID ASSEMBLY INHIBITOR
    Publication number: 20190298726
    Abstract: The present invention is directed to compositions and methods for treating hepatitis B virus infection. In particular, the present invention is directed to a combination therapy comprising administration of a TLR7 agonist and an HBV capsid assembly inhibitor for use in the treatment of chronic hepatitis B patient.
    Type: Application
    Filed: March 13, 2019
    Publication date: October 3, 2019
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Lue Dai, Lu Gao
  • COMBINED TREATMENT WITH A TLR7 AGONIST AND AN HBV CAPSID ASSEMBLY INHIBITOR
    Publication number: 20180000824
    Abstract: The present invention is directed to compositions and methods for treating hepatitis B virus infection. In particular, the present invention is directed to a combination therapy comprising administration of a TLR7 agonist and an HBV capsid assembly inhibitor for use in the treatment of chronic hepatitis B patient.
    Type: Application
    Filed: September 15, 2017
    Publication date: January 4, 2018
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Lue Dai, Lu Gao